Activatable Near-Infrared Fluorescence Imaging Using PEGylated Bacteriochlorin-Based Chlorin and BODIPY-Dyads as Probes for Detecting Cancer.


Journal

Bioconjugate chemistry
ISSN: 1520-4812
Titre abrégé: Bioconjug Chem
Pays: United States
ID NLM: 9010319

Informations de publication

Date de publication:
16 01 2019
Historique:
pubmed: 27 11 2018
medline: 4 1 2020
entrez: 27 11 2018
Statut: ppublish

Résumé

Near infrared (NIR) fluorescent probes are attractive tools for biomedical in vivo imaging due to the relatively deeper tissue penetration and lower background autofluorescence. Activatable probes are turned on only after binding to their target, further improving target to background ratios. However, the number of available activatable NIR probes is limited. In this study, we introduce two types of activatable NIR fluorophores derived from bacteriochlorin: chlorin-bacteriochlorin energy-transfer dyads and boron-dipyrromethene (BODIPY)-bacteriochlorin energy-transfer dyads. These fluorophores are characterized by multiple narrow excitation bands with relatively strong emission in the NIR. Targeted bacteriochlorin-based antibody or peptide probes have been previously limited by aggregation after conjugation. Polyethylene glycol (PEG) chains were added to improve the hydrophilicity without altering pharmacokinetics of the targeting moieties. These PEGylated bacteriochlorin-based activatable fluorophores have potential as targeted activatable, multicolor NIR fluorescent probes for in vivo applications.

Identifiants

pubmed: 30475591
doi: 10.1021/acs.bioconjchem.8b00820
pmc: PMC7307181
mid: NIHMS1590921
doi:

Substances chimiques

4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 0
Antibodies, Monoclonal 0
Boron Compounds 0
Fluorescent Dyes 0
Porphyrins 0
bacteriochlorin 0
Polyethylene Glycols 3WJQ0SDW1A

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-183

Subventions

Organisme : NCI NIH HHS
ID : U01 CA181628
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA BC011512
Pays : United States

Références

Chem Rev. 2010 May 12;110(5):2620-40
pubmed: 20000749
Acc Chem Res. 2011 Feb 15;44(2):83-90
pubmed: 21062101
Nature. 2008 Apr 3;452(7187):580-9
pubmed: 18385732
J Phys Chem B. 2011 Sep 22;115(37):10801-16
pubmed: 21875047
J Biomed Opt. 2007 Sep-Oct;12(5):051501
pubmed: 17994865
Bioconjug Chem. 2014 Feb 19;25(2):362-9
pubmed: 24450401
ACS Chem Biol. 2009 Jul 17;4(7):535-46
pubmed: 19480464
Chem Commun (Camb). 2011 Dec 14;47(46):12491-3
pubmed: 22020054
Bioconjug Chem. 2013 May 15;24(5):811-6
pubmed: 23600922
New J Chem. 2016;40(9):7721-7740
pubmed: 28154477
Theranostics. 2011;1:354-62
pubmed: 21938263
Biochem Biophys Res Commun. 2006 Sep 29;348(3):807-13
pubmed: 16904640
Adv Drug Deliv Rev. 2005 Jun 15;57(8):1087-108
pubmed: 15908041
Chem Soc Rev. 2011 Sep;40(9):4626-48
pubmed: 21607237
ACS Appl Mater Interfaces. 2013 May 22;5(10):4107-12
pubmed: 23614822
J Magn Reson Imaging. 2009 Nov;30(5):999-1004
pubmed: 19856413
Radiology. 2003 Oct;229(1):3-8
pubmed: 14519861
Cancer Res. 2000 Sep 1;60(17):4953-8
pubmed: 10987312
Contrast Media Mol Imaging. 2010 Jan-Feb;5(1):1-8
pubmed: 20101762
Clin Cancer Res. 2016 Jun 15;22(12):2929-38
pubmed: 27306792
N Engl J Med. 2010 Sep 2;363(10):943-53
pubmed: 20818904
Chem Rev. 2011 Nov 9;111(11):6557-602
pubmed: 21866984
Acta Radiol. 2006 Apr;47(3):303-10
pubmed: 16613313
Bioconjug Chem. 1999 Sep-Oct;10(5):892-6
pubmed: 10502358
Cancer Res. 2013 Jan 15;73(2):855-64
pubmed: 23188503
Nanomedicine (Lond). 2011 Jun;6(4):715-28
pubmed: 21718180
Radiology. 2001 Nov;221(2):523-9
pubmed: 11687699
J Org Chem. 2017 Dec 15;82(24):13068-13075
pubmed: 29119786
Contrast Media Mol Imaging. 2014 May-Jun;9(3):187-210
pubmed: 24700747
Bioconjug Chem. 2012 Aug 15;23(8):1671-9
pubmed: 22799539
Radiology. 2001 May;219(2):316-33
pubmed: 11323453
J Org Chem. 2017 Jun 16;82(12):6054-6070
pubmed: 28516773
Adv Drug Deliv Rev. 2003 Sep 26;55(10):1261-77
pubmed: 14499706
Radiology. 1982 Apr;143(1):29-36
pubmed: 7063747
Theranostics. 2017 Aug 11;7(13):3369-3386
pubmed: 28900516
Clin Cancer Res. 2007 Nov 1;13(21):6335-43
pubmed: 17975145
Bioconjug Chem. 2009 Nov;20(11):2023-31
pubmed: 19839633
Cancer Res. 2009 Feb 15;69(4):1268-72
pubmed: 19176373
J Org Chem. 2010 Mar 5;75(5):1659-73
pubmed: 20121051
Sci Transl Med. 2016 Jan 6;8(320):320ra4
pubmed: 26738797
Nat Mater. 2011 Apr;10(4):324-32
pubmed: 21423187
Mol Imaging. 2009 Dec;8(6):341-54
pubmed: 20003892
J Org Chem. 2013 Nov 1;78(21):10678-91
pubmed: 24079536
Lancet. 2006 May 13;367(9522):1558-60
pubmed: 16698396
Photochem Photobiol. 2008 Sep-Oct;84(5):1061-72
pubmed: 18673324
J Am Chem Soc. 2003 Sep 3;125(35):10693-702
pubmed: 12940755
Org Process Res Dev. 2005;9(5):651-659
pubmed: 19132135

Auteurs

Fusa Ogata (F)

Molecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.

Tadanobu Nagaya (T)

Molecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.

Yasuhiro Maruoka (Y)

Molecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.

Joshua Akhigbe (J)

Department of Chemistry and Biochemistry , University of Maryland, Baltimore County , Baltimore , Maryland 21250 United States of America.

Adam Meares (A)

Department of Chemistry and Biochemistry , University of Maryland, Baltimore County , Baltimore , Maryland 21250 United States of America.

Melissa Y Lucero (MY)

Department of Chemistry and Biochemistry , University of Maryland, Baltimore County , Baltimore , Maryland 21250 United States of America.

Andrius Satraitis (A)

Department of Chemistry and Biochemistry , University of Maryland, Baltimore County , Baltimore , Maryland 21250 United States of America.

Daiki Fujimura (D)

Molecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.

Ryuhei Okada (R)

Molecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.

Fuyuki Inagaki (F)

Molecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.

Peter L Choyke (PL)

Molecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.

Marcin Ptaszek (M)

Department of Chemistry and Biochemistry , University of Maryland, Baltimore County , Baltimore , Maryland 21250 United States of America.

Hisataka Kobayashi (H)

Molecular Imaging Program, Center for Cancer Research , National Cancer Institute, National Institutes of Health , Bethesda , Maryland 20892 , United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH